Seçkin, G. Ş. Et Al. 2012. The effect of CC chemokine receptor (CCR5) 59029 gene polymorphism on the occurence and clinicopathological status of prostate cancer. American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Laboratory Exposition , (California, United States Of America).

Seçkin, G. Ş., Küçükgergin, C., Şanlı, M. Ö., Gökkuşu, C., & Çakmakoğlu, B., (2012). The effect of CC chemokine receptor (CCR5) 59029 gene polymorphism on the occurence and clinicopathological status of prostate cancer . American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Laboratory Exposition, California, United States Of America

Seçkin, Güzide Et Al. "The effect of CC chemokine receptor (CCR5) 59029 gene polymorphism on the occurence and clinicopathological status of prostate cancer," American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Laboratory Exposition, California, United States Of America, 2012

Seçkin, Güzide Ş. Et Al. "The effect of CC chemokine receptor (CCR5) 59029 gene polymorphism on the occurence and clinicopathological status of prostate cancer." American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Laboratory Exposition , California, United States Of America, 2012

Seçkin, G. Ş. Et Al. (2012) . "The effect of CC chemokine receptor (CCR5) 59029 gene polymorphism on the occurence and clinicopathological status of prostate cancer." American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Laboratory Exposition , California, United States Of America.

@conferencepaper{conferencepaper, author={Güzide Şule SEÇKİN Et Al. }, title={The effect of CC chemokine receptor (CCR5) 59029 gene polymorphism on the occurence and clinicopathological status of prostate cancer}, congress name={American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Laboratory Exposition}, city={California}, country={United States Of America}, year={2012}}